Implementation and acceptability of a heart attack quality improvement intervention in India: a mixed methods analysis of the ACS QUIK trial.


Journal

Implementation science : IS
ISSN: 1748-5908
Titre abrégé: Implement Sci
Pays: England
ID NLM: 101258411

Informations de publication

Date de publication:
06 02 2019
Historique:
received: 12 06 2018
accepted: 16 01 2019
entrez: 8 2 2019
pubmed: 8 2 2019
medline: 14 8 2019
Statut: epublish

Résumé

The ACS QUIK trial showed that a multicomponent quality improvement toolkit intervention resulted in improvements in processes of care for patients with acute myocardial infarction in Kerala but did not improve clinical outcomes in the context of background improvements in care. We describe the development of the ACS QUIK intervention and evaluate its implementation, acceptability, and sustainability. We performed a mixed methods process evaluation alongside a cluster randomized, stepped-wedge trial in Kerala, India. The ACS QUIK intervention aimed to reduce the rate of major adverse cardiovascular events at 30 days compared with usual care across 63 hospitals (n = 21,374 patients). The ACS QUIK toolkit intervention, consisting of audit and feedback report, admission and discharge checklists, patient education materials, and guidelines for the development of code and rapid response teams, was developed based on formative qualitative research in Kerala and from systematic reviews. After four or more months of the center's participation in the toolkit intervention phase of the trial, an online survey and physician interviews were administered. Physician interviews focused on evaluating the implementation and acceptability of the toolkit intervention. A framework analysis of transcripts incorporated context and intervening mechanisms. Among 63 participating hospitals, 22 physicians (35%) completed online surveys. Of these, 17 (77%) respondents reported that their hospital had a cardiovascular quality improvement team, 18 (82%) respondents reported having read an audit report, admission checklist, or discharge checklist, and 19 (86%) respondents reported using patient education materials. Among the 28 interviewees (44%), facilitators of toolkit intervention implementation were physicians' support and leadership, hospital administrators' support, ease-of-use of checklists and patient education materials, and availability of training opportunities for staff. Barriers that influenced the implementation or acceptability of the toolkit intervention for physicians included time and staff constraints, Internet access, patient volume, and inadequate understanding of the quality improvement toolkit intervention. Implementation and acceptability of the ACS QUIK toolkit intervention were enhanced by hospital-level management support, physician and team support, and usefulness of checklists and patient education materials. Wider and longer-term use of the toolkit intervention and its expansion to potentially other cardiovascular conditions or other locations where the quality of care is not as high as in the ACS QUIK trial may be useful for improving acute cardiovascular care in Kerala and beyond. NCT02256657.

Sections du résumé

BACKGROUND
The ACS QUIK trial showed that a multicomponent quality improvement toolkit intervention resulted in improvements in processes of care for patients with acute myocardial infarction in Kerala but did not improve clinical outcomes in the context of background improvements in care. We describe the development of the ACS QUIK intervention and evaluate its implementation, acceptability, and sustainability.
METHODS
We performed a mixed methods process evaluation alongside a cluster randomized, stepped-wedge trial in Kerala, India. The ACS QUIK intervention aimed to reduce the rate of major adverse cardiovascular events at 30 days compared with usual care across 63 hospitals (n = 21,374 patients). The ACS QUIK toolkit intervention, consisting of audit and feedback report, admission and discharge checklists, patient education materials, and guidelines for the development of code and rapid response teams, was developed based on formative qualitative research in Kerala and from systematic reviews. After four or more months of the center's participation in the toolkit intervention phase of the trial, an online survey and physician interviews were administered. Physician interviews focused on evaluating the implementation and acceptability of the toolkit intervention. A framework analysis of transcripts incorporated context and intervening mechanisms.
RESULTS
Among 63 participating hospitals, 22 physicians (35%) completed online surveys. Of these, 17 (77%) respondents reported that their hospital had a cardiovascular quality improvement team, 18 (82%) respondents reported having read an audit report, admission checklist, or discharge checklist, and 19 (86%) respondents reported using patient education materials. Among the 28 interviewees (44%), facilitators of toolkit intervention implementation were physicians' support and leadership, hospital administrators' support, ease-of-use of checklists and patient education materials, and availability of training opportunities for staff. Barriers that influenced the implementation or acceptability of the toolkit intervention for physicians included time and staff constraints, Internet access, patient volume, and inadequate understanding of the quality improvement toolkit intervention.
CONCLUSIONS
Implementation and acceptability of the ACS QUIK toolkit intervention were enhanced by hospital-level management support, physician and team support, and usefulness of checklists and patient education materials. Wider and longer-term use of the toolkit intervention and its expansion to potentially other cardiovascular conditions or other locations where the quality of care is not as high as in the ACS QUIK trial may be useful for improving acute cardiovascular care in Kerala and beyond.
TRIAL REGISTRATION
NCT02256657.

Identifiants

pubmed: 30728053
doi: 10.1186/s13012-019-0857-7
pii: 10.1186/s13012-019-0857-7
pmc: PMC6364470
doi:

Banques de données

ClinicalTrials.gov
['NCT02256657']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Pagination

12

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001422
Pays : United States
Organisme : Northwestern University Global Health Initiative
ID : UL1TR001422
Pays : International
Organisme : NHLBI NIH HHS
ID : R00 HL107749
Pays : United States

Investigateurs

G Vijayaraghavan (G)
Geevar Zachariah (G)
J Rajan (J)
S Sivasankaran (S)
Dorairaj Prabhakaran (D)
Donald M Lloyd-Jones (DM)
K Srinath Reddy (KS)
S Harikrishnan (S)
Robert O Bonow (RO)
Darwin R Labarthe (DR)
Sidney C Smith (SC)
Brahmajee Nallamothu (B)
Thomas Alexander (T)
Karla Hemming (K)
Simon Thom (S)
K R Sundaram (KR)
Lawton Cooper (L)
Lihui Zhao (L)
Mark D Huffman (MD)
P P Mohanan (PP)
Raji Devarajan (R)
Abigail S Baldridge (AS)
Dimple Kondal (D)
Mumtaj Ali (M)
Divin Davies (D)
Prasad Arumugan (P)
T C Aneesh (TC)

Références

JAMA. 2012 May 16;307(19):2041-9
pubmed: 22665103
Circ Cardiovasc Qual Outcomes. 2014 Mar;7(2):209-16
pubmed: 24619324
BMC Med Res Methodol. 2013 Sep 18;13:117
pubmed: 24047204
Am Heart J. 2015 Mar;169(3):349-55
pubmed: 25728724
Indian Heart J. 2017 Jan - Feb;69(1):93-100
pubmed: 28228314
Cochrane Database Syst Rev. 2010 Mar 17;(3):CD006632
pubmed: 20238347
Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):436-43
pubmed: 23800985
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
Eur Heart J. 2013 Jan;34(2):121-9
pubmed: 22961945
Circ Cardiovasc Qual Outcomes. 2017 Nov;10(11):
pubmed: 29133473
Lancet Glob Health. 2018 Nov;6(11):e1163-e1175
pubmed: 30309799
J Am Coll Cardiol. 2017 Jul 4;70(1):1-25
pubmed: 28527533
BMC Health Serv Res. 2011 Sep 02;11:211
pubmed: 21884618
Circulation. 2015 Jul 28;132(4):302-61
pubmed: 25547519
Indian Heart J. 2017 Apr;69 Suppl 1:S12-S19
pubmed: 28400033
Cochrane Database Syst Rev. 2012 Jun 13;(6):CD000259
pubmed: 22696318
JAMA. 2006 Apr 26;295(16):1912-20
pubmed: 16639050
Am Heart J. 2017 Mar;185:154-160
pubmed: 28267469
Natl Med J India. 2008 May-Jun;21(3):107-11
pubmed: 19004139
Circ Cardiovasc Qual Outcomes. 2014 Mar;7(2):217-26
pubmed: 24619325

Auteurs

Kavita Singh (K)

Centre for Chronic Disease Control, New Delhi, India.
Public Health Foundation of India, Gurgaon, India.

Raji Devarajan (R)

Centre for Chronic Disease Control, New Delhi, India.
Public Health Foundation of India, Gurgaon, India.

Padinhare P Mohanan (PP)

Westfort Hi-Tech Hospital, Ltd, Thrissur, India.
Cardiological Society of India - Kerala Chapter, Kerala, India.

Abigail S Baldridge (AS)

Department of Medicine, Northwestern University Feinberg School of Medicine, 680 N. Lake Shore Drive, Suite 1400, Chicago, IL, 60611, USA.

Dimple Kondal (D)

Centre for Chronic Disease Control, New Delhi, India.
Public Health Foundation of India, Gurgaon, India.

David E Victorson (DE)

Department of Medicine, Northwestern University Feinberg School of Medicine, 680 N. Lake Shore Drive, Suite 1400, Chicago, IL, 60611, USA.

Kunal N Karmali (KN)

Department of Medicine, Northwestern University Feinberg School of Medicine, 680 N. Lake Shore Drive, Suite 1400, Chicago, IL, 60611, USA.

Lihui Zhao (L)

Department of Medicine, Northwestern University Feinberg School of Medicine, 680 N. Lake Shore Drive, Suite 1400, Chicago, IL, 60611, USA.

Donald M Lloyd-Jones (DM)

Department of Medicine, Northwestern University Feinberg School of Medicine, 680 N. Lake Shore Drive, Suite 1400, Chicago, IL, 60611, USA.

Dorairaj Prabhakaran (D)

Centre for Chronic Disease Control, New Delhi, India.
Public Health Foundation of India, Gurgaon, India.
London School of Hygiene and Tropical Medicine, London, UK.

Shifalika Goenka (S)

Centre for Chronic Disease Control, New Delhi, India.
Public Health Foundation of India, Gurgaon, India.
Indian Institute of Public Health-Delhi, New Delhi, India.

Mark D Huffman (MD)

Department of Medicine, Northwestern University Feinberg School of Medicine, 680 N. Lake Shore Drive, Suite 1400, Chicago, IL, 60611, USA. Mark.Huffman@nm.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH